← FDA DRUG APPROVALS

FDA ANDA · ANDA087666

SULFINPYRAZONE

Sponsor: BARR

APPLICATION
ANDA087666
TYPE
ANDA
ORIGINAL APPROVAL
1982-09-17
LATEST ACTION
2003-01-02
ROUTE
ORAL
DOSAGE FORM
CAPSULE
MARKETING STATUS
Discontinued

Products

SULFINPYRAZONEDiscontinued
SULFINPYRAZONE 200MG · CAPSULE · ORAL

Approval history

2003-01-02Labeling · Supplement 25AP
1999-12-21Manufacturing (CMC) · Supplement 24AP
1999-05-20Manufacturing (CMC) · Supplement 23AP
1999-03-18Manufacturing (CMC) · Supplement 22AP
1998-12-01Manufacturing (CMC) · Supplement 21AP
1994-12-23Manufacturing (CMC) · Supplement 20AP
1994-10-11Manufacturing (CMC) · Supplement 19AP
1992-04-03Manufacturing (CMC) · Supplement 18AP
1992-04-03Manufacturing (CMC) · Supplement 16AP
1991-06-12Labeling · Supplement 15AP
1991-03-08Labeling · Supplement 14AP
1989-07-14Labeling · Supplement 13AP
1988-05-16Manufacturing (CMC) · Supplement 11AP
1988-05-16Manufacturing (CMC) · Supplement 9AP
1988-05-16Manufacturing (CMC) · Supplement 10AP
1987-03-20Manufacturing (CMC) · Supplement 8AP
1985-10-22Manufacturing (CMC) · Supplement 6AP
1985-10-22Manufacturing (CMC) · Supplement 5AP
1983-06-27Manufacturing (CMC) · Supplement 2AP
1982-09-17OriginalAP
VIEW ON DRUGS@FDA ↗

Related on SPEQ

Pharma industry →GMP discipline →FDA drug shortages →FDA enforcement & recalls →

Source: FDA Drugs@FDA. SPEQ is not affiliated with the FDA; this is a reference view of public FDA data, not medical, legal, or regulatory advice.

Weekly Briefing

Get the Weekly GxP Briefing

Curated regulatory intelligence — enforcement, recalls, guidance, and quality signals — in one practitioner-grade email each week. Free.

Read a past issue →